In vitro antigen ELISA for quality control of tetanus vaccines.

[1]  R. Tierney,et al.  Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed. , 2011, Biologicals : journal of the International Association of Biological Standardization.

[2]  Marlies Halder,et al.  The consistency approach for quality control of vaccines - a strategy to improve quality control and implement 3Rs. , 2011, Biologicals : journal of the International Association of Biological Standardization.

[3]  P. Rigsby,et al.  Collaborative study for the calibration of a replacement international standard for diphtheria toxoid adsorbed. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[4]  R. Tierney,et al.  Development and use of a novel in vitro assay for testing of diphtheria toxoid in combination vaccines. , 2009, Journal of immunological methods.

[5]  R. Tierney,et al.  Calibration of replacement international standards of diphtheria and tetanus toxoids for use in flocculation test. , 2008, Biologicals : journal of the International Association of Biological Standardization.

[6]  R. G. Das,et al.  WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland. , 2008, Vaccine.

[7]  V. V. Sviridov,et al.  Determination of Tetanus Toxin and Toxoid by ELISA Using Monoclonal Antibodies , 2004, Applied Biochemistry and Microbiology.

[8]  R. Jankov,et al.  Development of Sandwich Enzyme‐Linked Immunosorbent Assay for Determination of Tetanus Toxoid Concentration , 2004, Journal of immunoassay & immunochemistry.

[9]  Bernard Metz,et al.  Reduction of animal use in human vaccine quality control: opportunities and problems. , 2002, Vaccine.

[10]  G. Kersten,et al.  An in vitro approach in quality control of toxoid vaccines. , 2001, Vaccine.

[11]  Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine. , 1999, Biologicals : journal of the International Association of Biological Standardization.

[12]  C. Jones,et al.  Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. , 1996, Vaccine.

[13]  D. Sesardic,et al.  Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres. , 1996, Biologicals : journal of the International Association of Biological Standardization.

[14]  D. Sesardic,et al.  Interaction of Haemophilus influenzae type b conjugate vaccines with diphtheria-tetanus-pertussis vaccine in control tests. , 1994, Vaccine.

[15]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[16]  A. J. Sheppard,et al.  Production and characterization of monoclonal antibodies to tetanus toxin , 1984, Infection and immunity.

[17]  J. Lyng,et al.  The second international standard for tetanus toxoid (adsorbed). , 1984, Journal of biological standardization.

[18]  T. Sundaresan,et al.  International collaborative studies on potency assays of diphtheria and tetanus toxoids. , 1972, Bulletin of the World Health Organization.

[19]  V. K. Volk,et al.  Response to two small doses of tetanus toxoid singly or combined as DT or DTP. , 1963, Public health reports.

[20]  L. Levine,et al.  Factors affecting the efficiency of the aluminum adjuvant in diphtheria and tetanus toxoids. , 1955, Journal of Immunology.

[21]  Factors affecting the efficiency of combined prophylactics. I. Effect of diphtheria toxoid and pertussis vaccine on tetanus toxoid. , 1954, Journal of immunology.